loader
Please Wait
Applying Filters...

Information, Expiry & Status of FDA Orange Book Patents covering Letermovir

Menu
$ API Ref.Price (USD/KG) : 12,777Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 10MERCK SHARP DOHME

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass
Left Arrow
Right Arrow

01

arrow
Discovery on Target
Not Confirmed
arrow
Discovery on Target
Not Confirmed

LETERMOVIR

US Patent Number : 8513255

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 209939

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2024-05-22

blank

02

arrow
Discovery on Target
Not Confirmed
arrow
Discovery on Target
Not Confirmed

LETERMOVIR

US Patent Number : 8513255

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 209939

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2024-05-22

blank

03

arrow
Discovery on Target
Not Confirmed
arrow
Discovery on Target
Not Confirmed

LETERMOVIR

US Patent Number : RE46791

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 209940

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2029-01-18

blank

04

arrow
Discovery on Target
Not Confirmed
arrow
Discovery on Target
Not Confirmed

LETERMOVIR

US Patent Number : 10603384

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 209940

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2033-02-28

blank

05

arrow
Discovery on Target
Not Confirmed
arrow
Discovery on Target
Not Confirmed

LETERMOVIR

US Patent Number : RE46791

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 209939

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2029-01-18

blank

06

arrow
Discovery on Target
Not Confirmed
arrow
Discovery on Target
Not Confirmed

LETERMOVIR

US Patent Number : 8513255

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 209940

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2024-05-22

blank

07

arrow
Discovery on Target
Not Confirmed
arrow
Discovery on Target
Not Confirmed

LETERMOVIR

US Patent Number : RE46791

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 209939

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2029-01-18

blank

08

arrow
Discovery on Target
Not Confirmed
arrow
Discovery on Target
Not Confirmed

LETERMOVIR

US Patent Number : 10603384

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 209940

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2033-02-28

blank

09

arrow
Discovery on Target
Not Confirmed
arrow
Discovery on Target
Not Confirmed

LETERMOVIR

US Patent Number : RE46791

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 209940

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2029-01-18

blank

10

arrow
Discovery on Target
Not Confirmed
arrow
Discovery on Target
Not Confirmed

LETERMOVIR

US Patent Number : 8513255

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 209940

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2024-05-22

blank